Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus".
(Updates from 10:45 a.m. ET with closing information.) NEW YORK ( TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk on the Street" Wednesday. A new cholesterol drug from Regeneron Pharmaceuticals ( REGN) had very positive phase III results and Cramer said it's putting Merck's ( MRK) Zetia drug to shame. REGN jumped 6% to $17.22. BMO initiated Kroger ( KR) with a neutral rating. Cramer said he prefers Whole Foods Market ( WFM). KR rose 1% to $41.87. "Goldman Sachs blesses" American Tower ( AMT) by reiterating it as a buy, Cramer said, adding that the last thing we heard about the company involved accounting issues. AMT was 3.2% higher at $77.12. Deutsche Bank raised its price target on Cheniere Energy ( LNG). Even though the stock has quadrupled in value, it appears to still have upside, according to Cramer. LNG was up 3.5% on the day to $38.17. Stanley Black & Decker ( SWK) provided dismal guidance and had poor margins, said Cramer. "This is a disaster." SWK plummeted 14.3% to $76.75. Conversely, Abbott Laboratories ( ABT) beat earnings estimates and raised its dividend. Cramer thinks CEO Miles White is going great things and likes the dividend. ABT jumped 6.5% to $35.90. To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here. -- Written by Bret Kenwell in Petoskey, Mich. Follow @BretKenwell